Source: International Congress 2015 – COPD: chronic disease and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Francesca Bigazzi (Firenze, Italy), Francesca Bigazzi, Alessio Garcea, Elena Torricelli, Viola Bonti, Matteo Paoletti, Gianna Camiciottoli, Massimo Pistolesi. Can we consider the "frequent exacerbator" a reliable COPD phenotype?. Eur Respir J 2015; 46: Suppl. 59, 685

Member's Comments

No comment yet.

Related content which might interest you: Do inhaled corticosteroids reduce the frequent exacerbator phenotype in COPD - A little help by a multicenter survey Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 LATE-BREAKING ABSTRACT: Stratification of patients with COPD by frequence of exacerbations is an essential step for what to treat in COPD. - A survey in a real life COPD population Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Is an EXACT score applicable Japanese patients with COPD? Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 COPD patients may suffer from frequent exacerbations but mostly do not - Subpopulations of a real life survey in more than 1.700 patients Source: International Congress 2014 – COPD exacerbations Year: 2014 Is an interactive voice response system (IVRS) effective in contributing to avoiding unplanned admissions in chronic obstructive pulmonary disease (COPD) patients? Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016